Wolverine Trading’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$7.13M Buy
276,200
+104,600
+61% +$3.12M 0.01% 1149
2025
Q2
$4.55M Buy
171,600
+35,800
+26% +$942K ﹤0.01% 1119
2025
Q1
$3.48M Sell
135,800
-167,800
-55% -$5.3M ﹤0.01% 1228
2024
Q4
$12.1M Buy
303,600
+109,800
+57% +$6.26M 0.01% 694
2024
Q3
$11.9M Buy
193,800
+88,400
+84% +$5.19M 0.01% 613
2024
Q2
$5.59M Sell
105,400
-38,500
-27% -$2.52M 0.01% 922
2024
Q1
$11.8M Buy
143,900
+57,800
+67% +$2.57M 0.01% 592
2023
Q4
$1.6M Buy
86,100
+25,200
+41% +$330K ﹤0.01% 1876
2023
Q3
$674K Sell
60,900
-51,900
-46% -$742K ﹤0.01% 2469
2023
Q2
$1.76M Buy
112,800
+15,500
+16% +$325K ﹤0.01% 1553
2023
Q1
$1.69M Buy
97,300
+6,700
+7% +$69.2K ﹤0.01% 1480
2022
Q4
$852K Buy
+90,600
New +$404K ﹤0.01% 1952
2022
Q3
Sell
-33,500
Closed -$93K 5425
2022
Q2
$93K Buy
33,500
+22,900
+216% +$56.7K ﹤0.01% 3870
2022
Q1
$32K Sell
10,600
-10,600
-50% -$38K ﹤0.01% 5179
2021
Q4
$98K Buy
+21,200
New +$119K ﹤0.01% 5101
2021
Q3
Sell
-19,400
Closed -$120K 7025
2021
Q2
$120K Sell
19,400
-16,300
-46% -$96.8K ﹤0.01% 5314
2021
Q1
$216K Buy
+35,700
New +$251K ﹤0.01% 4953
2020
Q4
Sell
-61,600
Closed -$365K 5538
2020
Q3
$365K Sell
61,600
-22,100
-26% -$152K ﹤0.01% 3152
2020
Q2
$608K Buy
83,700
+8,800
+12% +$58.4K ﹤0.01% 2528
2020
Q1
$355K Buy
+74,900
New +$460K ﹤0.01% 3043
2019
Q4
Sell
-112,500
Closed -$781K 5272
2019
Q3
$781K Buy
+112,500
New +$836K ﹤0.01% 2177
2019
Q1
Sell
-113,500
Closed -$859K 5377
2018
Q4
$859K Sell
113,500
-23,500
-17% -$281K ﹤0.01% 2108
2018
Q3
$2.39M Buy
+137,000
New +$1.63M 0.01% 1518

Other funds holding VKTX